Treating frostbite infections and studying antibiotics
Part of Injuries & trauma clinical trials.
This trial tests how well different treatments (like aloe vera, silver, and an antibiotic called dalbavancin) prevent and treat infections in people with frostbite. It also studies how these medicines work in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older but younger than 99.
- You are being treated at the UCHealth Burn Center for frostbite.
- You can join the prevention part if you've been seen within 4 days of getting frostbite and do not already have an infection.
- You can join the infection treatment part if you have a frostbite wound that is infected or suspected to be infected.
- You are not pregnant, not a prisoner, and do not have a condition that makes certain medicines unsafe for you.
- You or a family member can agree to the study in writing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding epoprostenol to standard care can help people with severe frostbite avoid amputation. Epoprostenol is a medicine that opens blood vessels to improve blood flow to damaged tissue.
This trial tests a new way of giving antibiotics to people with severe open fractures in the leg, ankle, or foot. The goal is to see if it helps prevent infections after surgery.
This trial tests whether dalbavancin (an antibiotic given as a dose or doses) works as well as standard antibiotics to treat bloodstream infections related to a removed IV catheter caused by Staphylococcus aureus. It may help reduce treatment time and dosing complexity if you qualify.
This Phase 3 study tests whether giving preventive antibiotics lowers infection risk when you need surgery to remove burned skin and place a skin graft. It may help patients heal with fewer serious infections, but it also depends on your antibiotic allergy and current health status.
This trial tests a new antibacterial wound dressing to see if it helps heal diabetic foot ulcers safely. It may be an option if your ulcer has been there for over 4 weeks and is not severely infected.
This trial tests BSG005, a new IV medicine for patients with invasive fungal infections that haven't improved with standard treatment or can't use standard treatments due to side effects or resistance. The goal is to see if it's safe and effective.
Hear when a new Frostbite trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.